Frontlight ResearchEarly access
CompletedNo phase
Defocus (DIMS) Spectacles Versus Ortho-K Lenses (OKL) for Slowing Myopia Progression in Children Aged 6-12 Years.
Key facts
- Who runs it
- Vejle Hospital
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 90 people enrolled
- Started
- 29 Jun 2022
- Ended
- 2 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Defocus Incorporated Multiple Segment (DIMS) Spectacles
- Orthokerathology lenses (OKL)
- Record updated
- 7 January 2026
Who can take part
- Age
- 6 years to 12 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Myopic children aged 6 to 12 years: Myopia of the 6 to 8-year-olds (inclusive): -1.00 to -4.75 D spherical component and up to -2.50 D of regular astigmatism (both eyes); Myopia of the 9 to 12-year-olds (inclusive): -2.00 to -4.75 D spherical component and up to -2.50 D of regular astigmatism (both eyes)
- Anisometropia ≤ 1.50 D cycloplegic spherical equivalent refractive error
- Best corrected visual acuity at age 6 to 12 years (inclusive): 0.8 Snellen (equivalent to ≥ 3/5 letter on the 0.8 line = 78 ETDRS letters)
Who cannot take part
- Previous eye surgery
- Previous myopia control treatment
- Contraindications to the use of OKL comprising (not exhaustive): keratoconus, chronic allergic conjunctivitis and keratoconjunctivitis sicca
- Chronic eye disease demanding daily use of eye drops
- Manifest or intermittent squint
- Non-compliance to eye examinations (unstable fixation or anxiety towards contact lenses)
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this non-inferiority randomized clinical trial is to compare the myopia control efficacy of Ortho-K lenses (OKL) and Defocus (DIMS) spectacles in myopic children aged 6-12 years. The main question it aims to answer is:
Read full original descriptionShow less
- Is the DIMS spectacle lens not worse than the OKL after 18 months of therapy?
The participants are randomly assigned to either OKL or DIMS spectacles and followed during 18 months of therapy.
The 2 groups in the trial
- OKLExisting treatment, for comparison
Treatment: Orthokerathology lenses (OKL)
- DIMSTreatment being tested
Treatment: Defocus Incorporated Multiple Segment (DIMS) Spectacles
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Defocus Incorporated Multiple Segment (DIMS) Spectacle Lenses Versus Orthokeratology Lenses (OKL) for Slowing Myopia Progression In Children Aged 6-12 Years. A Non-inferiority Randomized Clinical Trial. The NISDO Study.
- Publications
- Record updated
- 7 January 2026